OTCMKTS:IVOB - Invo Bioscience Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.40 -0.04 (-9.09 %) (As of 12/9/2018 04:00 PM ET)Previous Close$0.40Today's Range$0.40 - $0.488552-Week Range$0.08 - $0.77Volume46,645 shsAverage Volume51,763 shsMarket Capitalization$61.38 millionP/E RatioN/ADividend YieldN/ABeta-0.82 ProfileDiscussionChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email INVO Bioscience, Inc. provides solutions in assisted reproductive technologies to the reproductive health care community in the United States, Asia, South America, Central America, Europe, the Middle East, India and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVOcell Retention Device, a single-use, modified diaphragm that includes holes to allow for natural drainage of vaginal fluids; and INVO Holding/Warming Blocks that acts as a tool for viewing and retrieving the embryos from the inner chamber. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors. INVO Bioscience, Inc. is based in Medford, Massachusetts. Receive IVOB News and Ratings via Email Sign-up to receive the latest news and ratings for IVOB and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:IVOB Previous Symbol CUSIPN/A Webwww.invobioscience.com Phone978-878-9505 Debt Debt-to-Equity RatioN/A Current Ratio0.17 Quick Ratio0.16 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$280,000.00 Price / Sales219.21 Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / Book-10.00 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-700,000.00 Net Margins-500.71% Return on EquityN/A Return on Assets-87.97% Miscellaneous Employees1 Outstanding Shares153,450,000Market Cap$61.38 million OptionableNot Optionable Invo Bioscience (OTCMKTS:IVOB) Frequently Asked Questions What is Invo Bioscience's stock symbol? Invo Bioscience trades on the OTCMKTS under the ticker symbol "IVOB." How were Invo Bioscience's earnings last quarter? Invo Bioscience Inc (OTCMKTS:IVOB) posted its earnings results on Tuesday, August, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $0.11 million during the quarter. View Invo Bioscience's Earnings History. When is Invo Bioscience's next earnings date? Invo Bioscience is scheduled to release their next quarterly earnings announcement on Thursday, April 4th 2019. View Earnings Estimates for Invo Bioscience. Has Invo Bioscience been receiving favorable news coverage? News coverage about IVOB stock has been trending somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Invo Bioscience earned a coverage optimism score of 0.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. Who are some of Invo Bioscience's key competitors? Some companies that are related to Invo Bioscience include Pulse Biosciences (PLSE), T2 Biosystems (TTOO), RenovaCare (RCAR), RA Medical Systems (RMED), Alphatec (ATEC), Sensus Healthcare (SRTS), Apollo Endosurgery (APEN), STRATA Skin Sciences (SSKN), Endologix (ELGX), Arch Therapeutics (ARTH), iCAD (ICAD), Pro-Dex (PDEX), CAS Medical Systems (CASM), Repro-Med Systems (REPR) and Motus GI (MOTS). Who are Invo Bioscience's key executives? Invo Bioscience's management team includes the folowing people: Ms. Kathleen T. Karloff, Chairman, CEO & Pres (Age 63)Mr. Robert Joseph Bowdring Jr., Acting CFO, Treasurer, Sec., Consultant & Director (Age 60)Dr. Kevin Doody, Medical Director & Director (Age 56) How do I buy shares of Invo Bioscience? Shares of IVOB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Invo Bioscience's stock price today? One share of IVOB stock can currently be purchased for approximately $0.40. How big of a company is Invo Bioscience? Invo Bioscience has a market capitalization of $61.38 million and generates $280,000.00 in revenue each year. Invo Bioscience employs 1 workers across the globe. What is Invo Bioscience's official website? The official website for Invo Bioscience is http://www.invobioscience.com. How can I contact Invo Bioscience? Invo Bioscience's mailing address is 407R MYSTIC AVENUE SUITE 34C, MEDFORD MA, 02155. The company can be reached via phone at 978-878-9505 or via email at [email protected] MarketBeat Community Rating for Invo Bioscience (OTCMKTS IVOB)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 73 (Vote Outperform)Underperform Votes: 57 (Vote Underperform)Total Votes: 130MarketBeat's community ratings are surveys of what our community members think about Invo Bioscience and other stocks. Vote "Outperform" if you believe IVOB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVOB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/9/2018 by MarketBeat.com StaffFeatured Article: How does the Federal Reserve determine interest rates?